See More. Treat Better. Reduce Recurrence.
Bladder cancer affects over 3 million people worldwide1 and has one of the highest recurrence rates — up to 70% after initial transurethral resection of bladder tumor (TURBT)2 — making it one of the most costly and burdensome cancers to manage.
Olympus aims to reduce bladder cancer recurrence through improved detection and resection of NMIBC tumors, enhancing health outcomes and patient experiences.
Why Choose Olympus?
- See What Others Miss — 4K imaging, Narrow Band Imaging (NBI) and blue light technology (BL) for cystoscopy to enhance lesion detection.
- Resect with Confidence — PLASMA+ bipolar resection system for precise and controlled tumor removal.
- Innovate Every Step — VISERA S for outpatient detection and follow-up and 4K pendulum camera head for high-resolution surgeries.
Scroll further to experience the future of NMIBC care.